Literature DB >> 7001492

Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.

R Müller, F Lebrach.   

Abstract

The pathophysiology of disturbances in platelet function and intravasal hypercoagulability in diseases with impaired microcirculation is reviewed, and related relevant experimental and clinical findings with pentoxifylline are presented. Recent studies have revealed the antithrombotic properties of pentoxifylline which contribute to its haemorheological profile and therapeutical efficacy.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7001492

Source DB:  PubMed          Journal:  Pharmatherapeutica        ISSN： 0308-051X


  5 in total

1.  Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy.

Authors:  S B Solerte; M Fioravanti; A L Patti; N Schifino; M G Zanoletti; V Inglese; E Ferrari
Journal:  Acta Diabetol Lat       Date:  1987 Jul-Sep

Review 2.  Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Authors:  A Ward; S P Clissold
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

3.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

Review 4.  Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.

Authors:  S P Clissold; S Lynch; E M Sorkin
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

5.  Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study.

Authors:  S B Solerte; M Fioravanti; A Bozzetti; N Schifino; A L Patti; P Fedele; C Viola; E Ferrari
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.